VXTR.V Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: June 26, 2025
Report Source: 2025 1st Quarter Report
Voxtur Analytics Corp. Stock Analysis VXTR.V
Voxtur Analytics Corp. is a transformational real estate technology company. The company is headquartered in London, Ontario. The company went IPO on 2007-08-31. The firm offers automated workflows and targeted data analytics to simplify property valuation, default solutions, tax solutions and title and settlement services for investors, lenders, government agencies and mortgage servicers. The Company’s data hub and workflow platforms efficiently value real estate assets, to originate and service loans, securitize portfolios and evaluate tax assessments. The company serves the property lending and property tax sectors, both public and private. The company has developed a Web-based enterprise platform and database to deliver offerings, such as software and data licenses, technology-managed services, and settlement services. Software and Data Licenses include digital platforms that allow mortgage originators and investors to view their mortgage asset portfolios and analyze transactional data in real time. Settlement Services include provision of full-service title, escrow and closing services.
Read More Voxtur Analytics Corp (VXTR.V) Chart
Key Statistics of Voxtur Analytics Corp (VXTR.V)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.01Volume
1.01MP/E Ratio (TTM)
-52 Week Range
Market Cap
3.89MAvg. Volume
2.09MDividend Yield
-Financial Metrics & Statements of Voxtur Analytics Corp (VXTR.V)
FAQ's for Voxtur Analytics Corp (VXTR.V)
- According to Musaffa’s Shariah screening methodology, Voxtur Analytics Corp (VXTR.V) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.